Glenmark Pharma climbs nearly 7 percent on smart Q3 earnings
New Delhi : Shares of Glenmark Pharmaceuticals jumped nearly 7 per cent after the company reported an over two-fold jump in consolidated net profit for the December quarter.
The stock climbed 6.86 per cent to Rs 970.25 on BSE.
On NSE, it soared 6.7 per cent to Rs 970.
The drug firm yesterday reported an over two-fold jump in its consolidated net profit at Rs 477.03 crore for the December quarter, mainly on account of robust sales in the US market.
The figure for the same period of the previous fiscal stood at Rs 196.17 crore, the company said in a filing to BSE.
Consolidated total income from operations also rose to Rs 2,535 crore for the quarter under review, from Rs 1,778.29 crore a year ago.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd